ReviewMedicina (Kaunas, Lithuania)2025
The Pullback Pressure Gradient: Transforming Invasive Coronary Physiology from Lesion Assessment to Disease Pattern Characterization-A Perspective.
Review in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ultreon 3.0 and physiological coronary assessment: initial single-center Polish experience.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026Article
- Comparative effectiveness and outcomes of physiology- and imaging-guided PCI: an evidence synthesis and network meta-analysis of FFR, iFR, OCT, and IVUS.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This perspective comprehensively analyzes the invasive pullback pressure gradient (PPG), a novel physiological index that characterizes the longitudinal distribution of coronary artery disease and guides revascularization strategy modified in 14% of patients in the PPG Global Registry based on PPG assessment. We trace the historical development from subjective pullback curve analysis to a standardized, quantitative metric and describe the procedural aspects of both motorized and manual PPG acquisition. We synthesize evidence supporting PPG's clinical utility in predicting post-percutaneous coronary intervention outcomes, guiding revascularization decisions, and improving patient-centered outcomes. A central focus is PPG's mechanistic role in explaining the physiological basis of discordance between fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR), linking focal disease to FFR-positive/iFR-negative patterns and diffuse disease to FFR-negative/iFR-positive patterns. We conclude that PPG represents a fundamental advancement in coronary physiology, shifting clinical focus from individual stenoses to overall disease patterns. This paradigm shift provides deeper understanding of coronary artery disease pathophysiology and offers a powerful predictive tool to guide personalized revascularization strategies. Prospective randomized trials will be essential to solidify its role as a cornerstone of modern interventional cardiology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.